Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Julian
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   33    
Direct Shares   1,028,565    

Indirect Shares

   243,774,473      
Direct Value   $73,841,312    

Indirect Value

   $16,621,918,985      
Total Shares   244,803,038      
Total Value   $16,695,760,297      


Incyte Corp $32,141,876 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,141,833 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,488,073 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $287,451 Incyte Corp $32,141,876 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,141,833 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,488,073 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $287,451
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    46   
    7    

     Stock price went up :
    23   
    7    
     Stock price went down :
    23   
    0    
   
     Gain/Loss Ratio :
   0.0   
   7.0   
     Percentage Gain/Loss :
   11.8%
 80.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA 10% Owner 2003-09-26 0 2011-11-02 144,082    Premium*  
            Innoviva Inc INVA Director 2005-12-13 0 2004-10-04 33,839    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2004-10-13 0 2011-06-30 4,045,398    Premium*  
            Incyte Corp INCY 2024-05-07 559,963 2024-05-07 33,496,391    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2019-08-29 0 2019-08-29 9,262,659    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 2009-01-23 0 2009-01-23 2,258    Premium*  
            Viropharma Inc VPHM 10% Owner 0 2011-12-14 9,840,469    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2009-10-19 5,264,782    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2012-01-27 0    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 2011-08-22 0 2012-02-10 557,211    Premium*  
            XOMA Corporation XOMA Former 10% owner 0 2015-07-22 90,538    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 3,540,015    Premium*  
            Neurogene NGNE Director 2020-07-07 4,520 2020-07-07 3,501,691    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2021-06-22 205,752 2021-06-22 38,452,877    Premium*  
            Invitae Corp NVTA 10% Owner 2018-03-28 0 2018-03-28 7,553,553    Premium*  
            Aceragen, Inc ACGN 10% Owner 2019-07-01 43,858 2019-07-01 4,290,995    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM Former 10% owner 2017-10-05 0 2017-10-05 1,878,242    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-08 274 2017-11-08 35,999    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2018-01-17 0 2018-01-19 58,131    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2021-06-16 20,838 2021-06-16 11,703,086    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2021-05-14 46,557 2021-05-14 43,309,073    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2020-05-14 131,963 2020-05-14 7,940,623    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director, 10% Owner 2019-06-06 14,840 2019-06-06 2,700,597    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2018-10-09 0 2021-09-30 13,526,726    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 3,223,030    Premium*  
            Igm Biosciences, Inc. IGMS Director, 10% Owner 2019-09-20 0 2021-01-27 2,895,306    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2021-01-27 9,252,951    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 0 2021-01-01 4,286,038    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 0 2021-02-17 7,003,766    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE Director 0 2021-02-23 3,410,106    Premium*  
            Tscan Therapeutics, Inc. TCRX Director 2021-07-20 0 2021-07-20 1,320,302    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 0 2021-12-14 4,704,419    Premium*  
            Bicycle Therapeutics Ltd BCYC 0 2024-04-18 6,449,320    Premium*  
* Premium Members only  

Records found :    496         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 18 of 20
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KOD Kodiak Sciences Inc. Director   –       •       •   2021-08-11 4 B $84.39 $4,609,090 I/I 53,523 13,048,008 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2020-09-23 4 B $51.97 $4,826,756 I/I 92,069 11,246,368 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2021-06-29 4 B $89.87 $4,892,033 I/I 54,078 12,838,908 2.25 %
NVTA Invitae Corp 10% Owner   –       –       •   2018-03-28 4 B $4.50 $5,000,000 I/I 1,111,111 7,480,182 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2021-09-07 4 B $92.88 $5,365,227 I/I 57,501 13,269,155 2.25 %
VPHM Viropharma Inc 10% Owner   –       –       •   2010-04-30 4 B $12.76 $5,503,790 I/I 431,154 9,080,664 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2020-09-08 4 B $45.88 $5,505,934 I/I 116,295 11,090,409 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2020-02-26 4 B $57.82 $5,799,441 I/I 100,000 10,464,977 2.25 %
XOMA XOMA Corporation Director   –       •       •   2014-12-04 4 S $4.55 $5,928,902 I/I (1,304,288) 473,764 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2020-09-03 4 B $46.97 $5,942,904 I/I 123,883 10,905,982 2.25 %
NGNE Neurogene Director   –       •      –    2020-07-07 4 B $15.25 $6,466,000 I/I 424,000 3,501,691 2.1 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2008-12-19 4 B $11.14 $6,563,343 I/I 589,169 3,193,943 1.5 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2020-03-18 4 B $81.09 $6,673,935 I/I 81,379 7,841,556 2.1 %
KOD Kodiak Sciences Inc. Director   –       •       •   2020-08-21 4 B $47.74 $6,762,056 I/I 139,044 10,791,092 2.25 %
SGEN Seagen Inc Director   –       •       •   2018-05-08 4 B $54.02 $6,828,339 I/I 126,399 45,825,986 2.25 -
NGNE Neurogene 10% Owner   –       –       •   2017-01-09 4 B $15.13 $6,836,813 I/I 398,062 9,764,459 1.5 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2019-05-30 4 S $120.12 $6,949,754 I/I (57,449) 7,382,978 0 -
SGEN Seagen Inc Director   –       •       •   2018-05-07 4 B $53.70 $6,966,305 I/I 129,715 45,699,587 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2020-03-17 4 B $31.00 $7,218,907 I/I 219,800 38,309,339 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2021-08-19 4 B $86.94 $7,323,898 I/I 83,648 13,211,654 2.25 %
VPHM Viropharma Inc 10% Owner   –       –       •   2010-04-28 4 B $12.70 $7,638,151 I/I 600,619 7,735,006 1.5 -
GHDX Genomic Health Inc Director   –       •      –    2006-12-01 4 B $18.95 $7,705,696 I/I 380,870 1,093,914 2.1 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2020-03-17 4 B $76.10 $7,836,585 I/I 102,421 7,720,234 2.1 %
VPHM Viropharma Inc 10% Owner   –       –       •   2011-12-14 4 B $27.29 $7,960,161 I/I 291,706 9,840,469 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2021-09-30 4 B $95.83 $8,330,572 I/I 86,932 13,526,726 2.25 %
  496  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18  19   20      
  Page 18 of 20  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us